Home › Carcinoma a cellule squamose › Pennsylvania › Pittsburgh
Studi clinici su Carcinoma a cellule squamose a Pittsburgh, PA
10 studi su Carcinoma a cellule squamose cercano partecipanti presso sedi a Pittsburgh e dintorni (entro circa 30 miglia). Apri uno studio per vedere chi può partecipare e come contattare il team.
Testo ufficiale dello studio (inglese)
Stai reclutando per uno studio? Mettilo in evidenza in cima alla pagina — $99 per 30 giorni →
A Study to Investigate Safety of AZD6750 in Adult Participants With Select Advanced or Metastatic Solid Tumors
In reclutamentoFase 1/2
- Research Site, Pittsburgh
Transoral Surgical Resection Followed by De-escalated Adjuvant IMRT in Resectable p16+ Locally Advanced Oropharynx Cancer
In reclutamentoFase 2
- UPMC Hillman Cancer Center, Pittsburgh
Intralesional 5-Fluorouracil (5FU), Topical Calcipotriene Treatment for SCC
In reclutamentoFase 1Volontari sani benvenuti
- St. Margaret Hospital Dermatology, Pittsburgh
Radiotherapy With Cisplatin vs. Docetaxel-cetuximab in HNSCC: ERCC1 Biomarker Enrichment and Interaction Design
In reclutamentoFase 2
- UPMC Hillman Cancer Center - Radiation Oncology, Pittsburgh
Patient Preference for Subcutaneous vs. Intravenous Immune Therapy
In reclutamentoFase 2
- UPMC Hillman Cancer Center, Pittsburgh
A Study of Ficlatuzumab in Combination With Cetuximab in Participants With Recurrent or Metastatic (R/M) HPV Negative Head and Neck Squamous Cell Carcinoma
In reclutamentoFase 3
- University of Pittsburgh Medical Center - Hillman Cancer Center, Pittsburgh
A Study of VET3-TGI in Patients With Solid Tumors
In reclutamentoFase 1
- UPMC- Hillman Cancer Center, Pittsburgh
Use of SPY Imaging System to Minimize Fistulas After Hypopharyngeal Reconstruction
In reclutamentoFase 2
- UPMC, Pittsburgh
A Clinical Study of Intratumoral MVR-T3011 (T3011) Given as a Single Agent and in Combination With Intravenous Pembrolizumab in Participants With Advanced or Metastatic Solid Tumors
In reclutamentoFase 1/2
- University of Pittsburgh Medical Center, Pittsburgh
Study of Safety and Tolerability of BCA101 Monotherapy and in Combination Therapy in Patients With EGFR-driven Advanced Solid Tumors
In reclutamentoFase 1
- UPMC Hillman Cancer Center, Pittsburgh
Studi su Carcinoma a cellule squamose in altre città
- Los Angeles, CA8 studi
- Boston, MA8 studi
- Houston, TX7 studi
- New York City, NY7 studi
- Nashville, TN7 studi
- Atlanta, GA5 studi
- Durham, NC4 studi
- Arlington, VA4 studi
- Tampa, FL4 studi
- Orlando, FL4 studi
- Queens, NY4 studi
- Washington, DC4 studi
Altri studi a Pittsburgh
- Cancro del polmone non a piccole cellule48 studi
- Cancro (tutti i tipi)41 studi
- Cancro al seno39 studi
- Cancro colorettale32 studi
- Cancro metastatico31 studi
- Melanoma31 studi
- Cancro ovarico30 studi
- Cancro dell'endometrio23 studi
- Cancro ai polmoni23 studi
- Cancro alla prostata23 studi
- Ictus22 studi
- Carcinoma a cellule squamose della testa e del collo22 studi
Fonte: ClinicalTrials.gov, dati recuperati il 5 ott 2026. Ogni studio stabilisce i propri criteri di idoneità; è il team di ricerca a decidere chi può partecipare.